P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus

Virology

Volumn 236, Issue 1, 1997, Pages 18-29

  Wang, Yilong ^a   Finan, Jon E ^a   Middeldorp, Jaap M ^b   Hayward, S Diane ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Organon Teknika   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; IMMUNOBLOTTING; INFECTION; MONONUCLEOSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSACTIVATION; VIRUS CELL INTERACTION;

ANIMALIA; HUMAN HERPESVIRUS 4;

EID: 0031572255     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8739     Document Type: Article

References (70)

1. Ambinder, R. F., Müllen, M., Chang, Y.-N., Hayward, G. S., and Hayward, S. D. (1991). Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J. Virol. 65, 1466-1478.
2. Ambinder, R. F., Shah, W. A., Rawlins, D. R., Hayward, G. S., and Hayward, S. D. (1990). Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA. J. Virol. 64, 2369-2379.
3. Artavanis-Tsakonas, S., Matsuno, K., and Fortini, M. E. (1995). Notch signaling. Science 268, 225-232.
4. Bochkarev, A., Barwell, J. A., Pfuetzner, R. A., Bochkareva, E., and Frappier, L. (1996). Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein, EBNA1, bound to DNA. Cell 84, 791-800.
5. Breeden, L., and Nasmyth, K. (1985). Regulation of the yeast HO gene. Cold Spring Harbor Symp. Quant. Biol. 50, 643-650.
6. Bruckner, R. C., Crute, J. J., Dodson, M. S., and Lehman, I. R. (1991). The herpes simplex virus 1 origin binding protein: A DNA helicase. J. Biol. Chem. 266, 2669-2674.
7. Bruni, R., and Roizman, B. (1996). Open reading frame P - A herpes simplex virus gene repressed during productive infection encodes a protein that binds a splicing factor and reduces synthesis of viral proteins made from spliced mRNA. Proc. Natl. Acad. Sci. USA 93, 10423-10427.
8. Chen, C., and Okayama, H. (1987). High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745-2752.
9. Chen, M.-R., Middeldorp, J. M., and Hayward, S. D. (1993). Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure. J. Virol. 67, 4875-4885.
10. Chen, M.-R., Zong, J.-C., and Hayward, S. D. (1994). Delineation of a sixteen amino acid sequence that forms a core DNA recognition motif in the Epstein-Barr virus EBNA-1 protein. Virology 205, 486-495.
11. Deb, T. B., and Datta, K. (1996). Molecular cloning of human fibroblast hyaluronic acid-binding protein confirms its identity with P-32, a protein co-purified with splicing factor SF2. J. Biol. Chem. 271, 2206-2212.
12. Durfee, T., Becherer, K., Chen, P.-L., Yeh, S.-H., Yang, Y., Kilburn, A. E., Lee, W.-H., and Elledge, S. J. (1993). The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev. 7, 555-569.
13. Eggleton, P., Ghebrehiwet, B., Coburn, J. P., Sastry, K. N., Zaner, K. S., and Tauber, A. I. (1994). Characterization of the human neutrophil C1q receptor and functional effects of free ligand on activated neutrophils. Blood 84(5), 1640-1649.
14. Eggleton, P., Ghebrehiwet, B., Sastry, K. N., Coburn, J. P., Zaner, K. S., Reid, K. B., and Tauber, A. I. (1995). Identification of a gC1q-binding protein (gC1q-R) on the surface of human neutrophils. Subcellular localization and binding properties in comparison with the cC1q-R. J. Clin. Invest. 95(4), 1569-1578.
15. Frappier, L., and O'Donnell, M. (1991a). Epstein-Barr virus nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 88, 10875-10879.
16. Frappier, L., and O'Donnell, M. (1991b). Overproduction, purification, and characterization of EBNA-1, the origin binding protein of EBV. J. Biol. Chem. 266, 7819-7826.
17. Frappier, L., and O'Donnell, M. (1992). EBNA-1 distorts oriP, the Epstein-Barr virus latent replication origin. J. Virol. 66, 1786-1790.
18. Gahn, T. A., and Sugden, B. (1995). An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J. Virol. 69, 2633-2636.
19. Ghebrehiwet, B., Kew, R. R., Gruber, B. L., Marchese, M. J., Peerschke, E. I., and Reid, K. B. (1995). Murine mast cells express two types of C1q receptors that are involved in the induction of chemotaxis and chemokinesis. J. Immunol. 155(5), 2614-2619.
20. Ghebrehiwet, B., Lim, B. L., Peerschke, E. I., Willis, A. C., and Reid, K. B. (1994). Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q. J. Exp. Med. 179(6), 1809-1821.
21. Goldsmith, K., Bendell, L., and Frappier, L. (1993). Identification of EBNA1 amino acid sequences required for the interaction of the functional elements of the Epstein-Barr virus latent origin of DNA replication. J. Virol. 67, 3418-3426.
22. Hearing, J., Mulhaupt, Y., and Harper, S. (1992). Interaction of Epstein-Barr virus nuclear antigen 1 with the viral latent origin of replication. J. Virol. 66, 694-705.
23. Hearing, J. C., and Levine, A. J. (1985). The Epstein-Barr virus nuclear antigen (BamHI K antigen) is a single-stranded DNA binding phosphoprotein. Virology 145, 105-116.
24. Heller, M., van Santen, V., and Kieff, E. (1982). Simple repeat sequence in Epstein-Barr virus DNA is transcribed in latent and productive infections. J. Virol. 44, 311-320.
25. Honore, B., Madsen, P., Rasmussen, H. H., Vandekerckhove, J., Celis, J. E., and Letters, H. (1993). Cloning and expression of a cDNA covering the complete coding region of the P32 subunit of human premRNA splicing factor SF2. Gene 134(2), 283-287.
26. Horner, D., Lewis, M., and Farrell, P. J. (1995). Novel hypotheses for the roles of EBNA-1 and BHRF1 in EBV-related cancers. Intervirology 38, 195-205.
27. Hsieh, D.-J., Camiolo, S. M., and Yates, J. L. (1993). Constitutive binding of EBNA-1 protein to the EBV replication origin, oriP, with distortion of DNA structure during latent infection. EMBO J. 12, 4933-4944.
28. Hsieh, J. J.-D., and Hayward, S. D. (1995). Masking of the CBF1/RBPJk transcriptional repression domain by Epstein-Barr virus EBNA2. Science 268, 560-563.
29. Hsieh, J. J.-D., Henkel, T., Salmon, P., Robey, E., Peterson, M. G., and Hayward, S. D. (1996). Truncated mammalian Notchl activates CBF1/ RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2. Mol. Cell. Biol. 16, 952-959.
30. Hsieh, J. J.-D., Nofziger, D. E., Weinmaster, G., and Hayward, S. D. (1997). EBV immortalization: Notch2 interacts with CBF1. J. Virol. 71, 1938-1945.
31. Jankelevich, S., Kolman, J. L., Bodnar, J. W., and Miller, G. (1992). A nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain. EMBO J. 11, 1165-1176.
32. Jarriault, S., Brou, C., Logeat, F., Schroeter, E. H., Kopan, R., and Israel, A. (1995). Signalling downstream of activated mammalian Notch. Nature 377, 355-358.
33. Kirchmaier, A. L., and Sugden, B. (1997). Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus. J. Virol. 71, 1766-1775.
34. Krainer, A. R., Conway, G. G., and Kozak, D. (1990). Purification and characterization of pre-mRNA splicing factor SF2 from HeLa cells. Genes Dev. 4, 1158-1171.
35. Krainer, A. R., Mayeda, A., Kozak, D., and Binns, G. (1991). Functional expression of cloned human splicing factor SF2: Homology to RNA-binding proteins, U1 70K, and Drosophila splicing regulators. Cell 66, 383-394.
36. Laine, A., and Frappier, L. (1995). Identification of Epstein-Barr virus nuclear antigen 1 protein domains that direct interactions at a distance between DNA-bound proteins. J. Biol. Chem. 270, 30914-30918.
37. Ling, P. D., Ryon, J. J., and Hayward, S. D. (1993). EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif. J. Virol. 67, 2990-3003.
38. Luo, Y., Yu, H., and Peterlin, B. M. (1994). Cellular protein modulates effects of human immunodeficiency virus type 1 Rev. J. Virol. 68, 3850-3856.
39. Mackey, D., Middleton, T., and Sugden, B. (1995). Multiple regions within EBNA1 can link DNAs. J. Virol. 69, 6199-6208.
40. Mayeda, A., Zahler, A. M., Krainer, A. R., and Roth, M. B. (1992). Two members of a conserved family of nuclear phosphoproteins are involved in pre-mRNA splicing. Proc. Natl. Acad. Sci. USA 89, 1301-1304.
41. Middleton, T., and Sugden, B. (1992). EBNA-1 can link the enhancer element to the initiator element of the Epstein-Barr virus plasmid origin of DNA replication. J. Virol. 66, 489-495.
42. Miller, G. (1990). Epstein-Barr virus. In "Virology" (B. N. Fields, D. M. Knipe, R. M. Chanock, M. S. Hirsch, J. L. Melnick, T. P. Monath, and B. Roizman, Eds.), 2nd ed., pp. 1921-1958. Raven Press, New York.
43. Nonkwelo, C., Skinner, J., Bell, A., Rckinson, A., and Sample, J. (1996). Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein. J. Virol. 70, 623-627.
44. Peerschke, E. I., Reid, K. B., and Ghebrehiwet, B. (1994). Identification of a novel 33-kDa C1q-binding site on human blood platelets. J. Immunol. 152(12), 5896-5901.
45. Polvino-Bodnar, M., and Schaffer, P. A. (1992). DNA binding activity is required for EBNA 1-dependent transcriptional activation and DNA replication. Virology 187, 591-603.
46. Puglielli, M. T., Woisetschlaeger, M., and Speck, S. H. (1996). oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines. J. Virol. 70, 5758-5768.
47. Rawlins, D. R., Milman, G., Hayward, S. D., and Hayward, G. S. (1985). Sequence specific DNA-binding of EBNA-1 to clustered sites in the plasmid maintenance region. Cell 42, 859-868.
48. Reisman, D., and Sugden, B. (1986). Transactivation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol. Cell. Biol. 6, 3838-3846.
49. Rckinson, A. B., and Kieff, E. (1996). Epstein-Barr virus. In "Field's Virology" (B. N. Field, D. M. Knipe, and P. M. Howley, Eds.), 3rd ed., Vol. 2, pp. 2397-2446. Raven Press, New York.
50. Sakai, J., Duncan, E. A., Rawson, R. B., Hua, X., Brown, M. S., and Goldstein, J. L. (1996). Sterol-regulated release of SREBP-2 from cell membranes requires two sequential cleavages, one within a transmembrane segment. Cell 85, 1037-1046.
51. Sample, J., Henson, E. B. D., and Sample, C. (1992). The Epstein-Barr virus nuclear protein 1 promoter active in type 1 latency is autoregulated. J. Virol. 66, 4654-4661.
52. Schaefer, B. C., Strominger, J. L., and Speck, S. H. (1995). Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc. Natl. Acad. Sci. USA 92, 10565-10569.
53. Schiestl, R. H., and Gietz, R. D. (1989). High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr. Genet. 16, 339-346.
54. Schlager, S., Speck, S. H., and Woisetschlager, M. (1996). Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells. J. Virol. 70, 3561-3570.
55. Shah, W. A., Ambinder, R. F., Hayward, G. S., and Hayward, S. D. (1992). Binding of EBNA-1 to DNA creates a protease-resistant domain that encompasses the DNA recognition and dimerization functions. J. Virol. 66, 3355-3362.
56. Smith, P. R., and Griffin, B. E. (1992). Transcription of the Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells. J. Virol. 66, 706-714.
57. Snudden, D. K., Hearing, J., Smith, P. R., Grasser, F. A., and Griffin, B. E. (1994). EBNA-1, the major nuclear antigen of Epstein-Barr virus, resembles "RGG" RNA binding proteins. EMBO J. 1354, 4840-4847.
58. Su, W., Middleton, T., Sugden, B., and Echols, H. (1991). DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: Stabilization of an origin complex with Epstein-Barr nuclear antigen 1. Proc. Natl. Acad. Sci. USA 88, 10870-10874.
59. Sugden, B., and Warren, N. (1989). A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J. Virol. 63, 2644-2649.
60. Sung, N. S., Wilson, J., Davenport, M., Sista, N. D., and Pagano, J. S. (1994). Reciprocal regulation of the Epstein-Barr virus SamHI-F promoter by EBNA-1 and an E2F transcription factor. Mol. Cell Biol. 14, 7144-7152.
61. Wilson, J. B., Bell, J. L., and Levine, A. J. (1996). Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J. 15, 3117-3126.
62. Wilson, J. B., and Levine, A. J. (1992). The oncogenic potential of Epstein-Barr virus nuclear antigen 1 in transgenic mice. Curr. Top. Microbiol. Immunol. 182, 375-384.
63. Wold, M. S., Li, J. J., and Kelly, T. J. (1987). Initiation of simian virus 40 DNA replication in vitro: Large-tumor-antigen- and origin-dependent unwinding of the template. Proc. Natl. Acad. Sci. USA 84, 3643-3647.
64. Wysokenski, D. A., and Yates, J. L. (1989). Multiple EBNA-1 binding sites are required to form an EBNA-1 dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. J. Virol. 63, 2657-2666.
65. Yang, L., Mohr, I., Fouts, E., Lim, D. A., Nohaile, M., and Botchan, M. (1993). The E1 protein of the papillomavirus BPV-1 is an ATP dependent DNA helicase. Proc. Natl. Acad. Sci. USA 90, 5086-5090.
66. Yates, J., Warren, N., Reisman, D., and Sugden, B. (1984). A cis acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. USA 81, 3806-3810.
67. Yates, J. L., and Camiolo, S. M. (1988). Dissection of DNA replication and enhancer activation functions of Epstein-Barr virus nuclear antigen 1. Cancer Cells 6, 197-205.
68. Yates, J. L., Warren, N., and Sugden, B. (1985). Stable replication of plasmids derived from Epstein-Barr virus in a variety of mammalian cells. Nature (London) 313, 812-815.
69. Yu, L., Loewenstein, P. M., Zhang, Z., and Green, M. (1995a). In vitro interaction of the human immunodeficiency virus type 1 Tat transactivator and the general transcription factor TFIIB with the cellular protein TAP. J. Virol. 69(5), 3017-3023.
70. Yu, L., Zhang, Z., Loewenstein, P. M., Desai, K., Tang, Q., Mao, D., Symington, J. S., and Green, M. (1995b). Molecular cloning and characterization of a cellular protein that interacts with the human immunodeficiency virus type 1 Tat transactivator and encodes a strong transcriptional activation domain. J. Virol. 69(5), 3007-3016.